Were Analysts Bullish Shire plc (LON:SHP) This Week?

May 16, 2018 - By Hazel Jackson

Shire plc (LON:SHP) Logo

Shire plc (LON:SHP) Ratings Coverage

Among 18 analysts covering Shire PLC (LON:SHP), 13 have Buy rating, 0 Sell and 5 Hold. Therefore 72% are positive. Shire PLC had 68 analyst reports since November 17, 2017 according to SRatingsIntel. The stock of Shire plc (LON:SHP) earned “Outperform” rating by BNP Paribas on Tuesday, January 16. The rating was maintained by Citigroup with “Buy” on Wednesday, February 21. Goldman Sachs maintained Shire plc (LON:SHP) rating on Monday, March 26. Goldman Sachs has “Conviction Buy” rating and GBX 4600 target. Shore Capital maintained the stock with “Buy” rating in Monday, April 16 report. The company was maintained on Monday, April 9 by BNP Paribas. Societe Generale maintained it with “Buy” rating and GBX 7500 target in Wednesday, March 14 report. The stock has “Outperform” rating by RBC Capital Markets on Wednesday, April 25. As per Wednesday, May 9, the company rating was maintained by Deutsche Bank. Shore Capital maintained the stock with “Buy” rating in Friday, February 23 report. The firm has “Hold” rating by Liberum Capital given on Wednesday, March 7. Below is a list of Shire plc (LON:SHP) latest ratings and price target changes.

10/05/2018 Broker: Kepler Cheuvreux Rating: Under Review Old Target: GBX 4250.00 Downgrade
09/05/2018 Broker: Deutsche Bank Rating: Buy Maintain
08/05/2018 Broker: Shore Capital Rating: Buy Old Target: GBX 4025.00 New Target: GBX 3856.00 Maintain
08/05/2018 Broker: Berenberg Rating: Buy Old Target: GBX 4500.00 Maintain
08/05/2018 Broker: Liberum Capital Rating: Hold Old Target: GBX 4000.00 Maintain
04/05/2018 Broker: Credit Suisse Rating: Outperform Old Target: GBX 4000.00 Maintain
27/04/2018 Broker: Kepler Cheuvreux Rating: Buy Old Target: GBX 4250.00 New Target: GBX 4250.00 Maintain
26/04/2018 Broker: Deutsche Bank Rating: Buy Old Target: GBX 3559.00 Maintain
25/04/2018 Broker: RBC Capital Markets Rating: Outperform Maintain
25/04/2018 Broker: Shore Capital Rating: Buy Old Target: GBX 3607.00 New Target: GBX 4025.00 Maintain

The stock increased 0.80% or GBX 33.5 during the last trading session, reaching GBX 4216. About 3.60 million shares traded. Shire plc (LON:SHP) has 0.00% since May 16, 2017 and is . It has underperformed by 11.55% the S&P500.

Shire plc, a biotechnology company, focused on serving people with rare diseases and other specialized conditions worldwide. The company has market cap of 38.22 billion GBP. The firm offers products in therapeutic areas, including hematology, genetic diseases, neuroscience, immunology, internal medicine, ophthalmology, and oncology. It has a 8.66 P/E ratio. The Company’s marketed products include ADVATE and ADYNOVATE/ADYNOVI for hemophilia A; RIXUBIS to treat hemophilia B; VONVENDI for the treatment of von willebrand Disease; FEIBA to treat hemophilia A and B patients with inhibitors; CINRYZE and FIRAZYR for hereditary angioedema; ELAPRASE to treat hunter syndrome; REPLAGAL for Fabry disease; and VPRIV to treat type 1 Gaucher disease.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.